The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The signature program, a series of tissue-agnostic, mutation-specific signal finding trials.
Eric Daniel Slosberg
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Other Remuneration - Novartis
Barinder Kang
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
J. Thaddeus Beck
Research Funding - Novartis
Sarina Anne Piha-Paul
Research Funding - Novartis
Robert J. Green
Employment or Leadership Position - Cancer clinics of excellence
Donald A. Richards
No relevant relationships to disclose
Christopher L. Corless
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Donald A. Berry
Consultant or Advisory Role - Novartis
Steven H. Stein
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Other Remuneration - Novartis
August J. Salvado
Employment or Leadership Position - Novartis
Stock Ownership - Novartis